Economic disparity across Europe's regions can be linked directly to investment in research and development and adoption of information technologies, says an official report.
York University's Centre for Novel Agricultural Products has won a grant from the Bill & Melinda Gates Foundation to complete research into an antimalarial plant.
Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.
Carlos Moreira, co-founder and chairman of Swiss data-encryption firm WISekey, talks to Science|Business editor Richard L. Hudson on the travails of entrepreneurship.
Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.
The European Commission launched a nine-week internet consultation with experts and the public, soliciting views on how to improve the welfare of laboratory animals.
A spin off from ETH-Zürich has devised a new generation of detection equipment that could help in the fight against terrorism. The company is now seeking investment and possible partnerships to take the technology to a commercial level.
A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.